Slide Added to Russell 2000(R) Index

(NASDAQ:SLDE), TAMPA, Fla., Sept. 22, 2025 (GLOBE NEWSWIRE) — Slide Insurance Holdings, Inc. (“Slide” or the “Company”) (Nasdaq: SLDE) today announced that it has joined the Russell 2000(R) Index, effective at the open of US equity markets on Monday, September 22, 2025 as part of the quarterly U.S. Russell Index Initial Public Offering (IPO) update. […]

SemiCab Wins Prestigious Logistics Award, Industry Recognition for Best Value Award

(NASDAQ:RIME), Company Wins Best Value Award at LogiMeet 2025 Fort Lauderdale, FL, Sept. 22, 2025 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME), an AI technology holding company announced today that its subsidiary, SemiCab Holdings, LLC (“SemiCab”), recently won the Best Value Award at LogiMeet 2025. This is a highly prestigious annual event, hosted

LifeVantage to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

(NASDAQ:LFVN), SALT LAKE CITY, Sept. 22, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Lytham Partners Fall

Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting

(NASDAQ:GRCE), PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) — Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for I.V. infusion to address significant unmet medical needs in aSAH patients, today announced that results from its Pivotal Phase 3

BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure

(NASDAQ:BCDA), SUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) — BioCardia(R), Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has had a positive preliminary clinical consultation with Japan's Pharmaceutical and Medical Device Agency (PMDA) on the CardiAMP Heart Failure Trial results previously provided to the

Connect Names Gretel von Son as Chief Operating Officer to Drive Growth in Entrepreneurship and Innovation

SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) — Connect, a premier nonprofit organization in San Diego's innovation ecosystem, dedicated to supporting entrepreneurs and cultivating thriving life science and technology communities, announced today the appointment of Gretel von Son as Chief Operating Officer. In this role, she will oversee operations and strategy, with a focus on

Lancaster Resources Secures District-Scale Expansion, Doubling Footprint at Lake Cargelligo Gold Project to 62,300 hectares

(CNSX:LCR.CN),(OTC US:LANRF),(Other OTC:LANRF),(Boerse Frankfurt – Freiverkehr:6UF0), VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) — Lancaster Resources Inc. (CSE:LCR) (OTCPink:LANRF) (FRA:6UF) (“Lancaster“), is pleased to announce that it has acquired additional mineral claims at the 100% owned Lake Cargelligo Gold Project in New South Wales, Australia, more than doubling the size of the property. These

ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study

(Madrid:ORY.MC),(Boerse Stuttgart – Freiverkehr:ORN),(Madrid:ORY),(Boerse Stuttgart – Freiverkehr:ORN.SG), Study led by CureShank Aims to characterize the direct and indirect burden of PMS to patients, caregivers, and US healthcare system MADRID and CAMBRIDGE, Mass., Sept. 22, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics,

Aventis Energy Confirms Strong Radioactivity During Successful Exploration Program at the Corvo Uranium Project

(CNSX:AVE),(CNSX:AVE.CN),(Frankfurt:C0O0),(OTC US:VBAMF),(Other OTC:VBAMF),(TSX-V:STND.V), VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) — Aventis Energy (“Aventis” or the “Company“) (CSE:AVE | FRA:C0O0 | OTC: VBAMF) is pleased to announce an update from its 2025 exploration program at the Corvo Uranium Project (“Corvo“, or the “Project“), currently under a three-year earn-in option agreement with Standard Uranium Ltd.

UMH PROPERTIES, INC. ANNOUNCES INCREASED STOCK REPURCHASE AUTHORIZATION TO $100 MILLION

(NYSE:UMH),(TASE:UMH),(TASE:UMH.TA), FREEHOLD, NJ, Sept. 22, 2025 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE: UMH; TASE: UMH), announced today that the Board of Directors has authorized the Company to repurchase up to $100 million of its outstanding common stock, an increase from the Board's previous authorization of up to $25 million of common stock repurchases. The

Scroll to Top